Related Experiment Video
Updated: Aug 19, 2025

07:19
Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
Published on: March 24, 2023
5.1K
Challenges in osteoarthritis treatment.
Asrin Emami1, Haideh Namdari1, Farzad Parvizpour2
1Iranian tissue bank and research center, Tehran University of Medical Sciences, Tehran, Iran.
Tissue & Cell
|December 3, 2022
Summary
Osteoarthritis (OA) is a common degenerative joint disease causing disability. This review summarizes new OA treatments and future research targets for pain, stiffness, and function.
Area of Science:
- Orthopedics
- Rheumatology
- Regenerative Medicine
Background:
- Osteoarthritis (OA) is the most prevalent form of arthritis and a leading cause of disability in the elderly worldwide.
- OA incurs significant social, psychological, and economic burdens.
- Current OA management focuses on pain reduction, stiffness relief, and function preservation.
Purpose of the Study:
- To review and discuss recent therapeutic advancements for osteoarthritis.
- To explore emerging treatment modalities and potential future research avenues for OA.
Main Methods:
- Literature review of recent studies on osteoarthritis treatments.
- Synthesis of findings on novel pharmacological and non-pharmacological interventions.
- Analysis of emerging targets in OA pathophysiology.
Main Results:
- Significant progress in understanding OA pathophysiology has led to diverse therapeutic advances.
- Potential treatments include tissue engineering, immune modulation, surgical innovations, and new drug therapies.
- No definitive cure exists; treatment is often stage-dependent.
Conclusions:
- Ongoing research is crucial for developing effective OA treatments.
- Future research should focus on novel targets and personalized therapeutic strategies.
- A comprehensive approach combining various modalities may offer the best outcomes for OA patients.
Related Concept Videos
Osteoclasts in Bone Remodeling
3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
Atherosclerosis III: Management
19
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Rheumatic Heart Disease III: Medical Management
26
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26

